New chemo combo aims to cut Long-Term harm in kids with AML

NCT ID NCT07059975

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This study tests whether replacing two standard chemotherapy cycles with new drug combinations is safe and effective for children and young adults with acute myeloid leukemia (AML) at intermediate or high risk of relapse. About 36 participants will receive the new cycles and be monitored for side effects and remission for up to three years. The goal is to maintain or improve survival while reducing long-term complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Texas Children's Cancer and Hematology Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.